What To Expect From PFE Stock In 2025?
Portfolio Pulse from
Pfizer's stock (NYSE: PFE) underperformed in 2024, losing about 5%, while the S&P 500 gained 23%. Other pharmaceutical companies like Eli Lilly and AbbVie saw significant gains.
January 15, 2025 | 3:30 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Pfizer's stock underperformed in 2024, losing 5% compared to the S&P 500's 23% gain. This indicates potential challenges or market conditions affecting Pfizer negatively.
Pfizer's stock performance lagged behind the broader market and its peers, suggesting potential issues or market conditions that may continue to affect its stock negatively in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100